Equity Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding, December 31, 2021		158,174		$	10.99		7.6	$	-
Granted		21,167		$	3.55		9.8	$	4,650
Exercised		-		$	-		-	$	-
Forfeited		(13,333	)	$	9.15		0.0	$	-
Expired		-		$	-		-	$	-
Outstanding, March 31, 2022		166,007		$	10.18		8.2	$	4,650
Exercisable, March 31, 2022		118,828		$	11.89		7.6	$	610

Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:

	Number of Options			Weighted Average Grant-Date Fair Value		Aggregate Intrinsic Value		Grant-Date Fair Value
Nonvested, December 31, 2021		41,846		$	7.65	$	-	$	320,122
Granted		21,167		$	3.51	$	-	$	74,296
Vested		(4,167	)	$	4.50	$	-	$	(18,751	)
Forfeited		(11,667	)	$	9.01	$	-	$	(105,120	)
Expired		-		$	-	$	-	$	-
Nonvested, March 31, 2022		47,179		$	5.73	$	-	$	270,547

Schedule of Restricted Stock Units Activity

	Number of Units			Weighted Average Grant-Date Fair Value		Aggregate Intrinsic Value
Outstanding, December 31, 2021		-		$	-	$	-
Granted		6,734		$	7.42	$	-
Vested and settled with share issuance		(3,367	)	$	7.42	$	-
Forfeited/canceled		-		$	-	$	-
Outstanding, March 31, 2022		3,367		$	7.42	$	-

2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding, December 31, 2021		50,872	$	10.02		6.6	$	-
Granted		6,250	$	4.80		9.8	$	-
Exercised		-	$	-		-	$	-
Forfeited/Cancelled		-	$	-		-	$	-
Expired		-	$	-		-	$	-
Outstanding, March 31, 2022		57,122	$	9.44		6.7	$	-
Exerciseable, March 31, 2022		57,122	$	9.44		6.7	$	-

Summary of Non-vested Non-qualified Stock Option Activity

	Number of Options			Weighted Average Grant-Date Fair Value		Aggregate Intrinsic Value			Grant-Date Fair Value
Nonvested, December 31, 2021		-		$	-	$	-		$	-
Granted		6,250		$	4.80	$	(14,313	)	$	29,688
Vested		(6,250	)	$	4.80	$	14,313		$	(29,688	)
Forfeited		-		$	-	$	-		$	-
Expired		-		$	-	$	-		$	-
Nonvested, March 31, 2022		-				$	-		$	-